Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.1.26.13 extracted from

  • Moelling, K.; Schulze, T.; Diringer, H.
    Inhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanions (1989), J. Virol., 63, 5489-5491.
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
Dextran sulfate more potent inhibitor of RNase H than of reverse transcriptase. 50% infective dose corresponds to 0.1 nM Human immunodeficiency virus 1
heparin more potent inhibitor of RNase H than of reverse transcriptase. 50% infective dose corresponds to 0.5-1.5 nM Human immunodeficiency virus 1
xylan polysulfate more potent inhibitor of RNase H than of reverse transcriptase. 50% infective dose corresponds to 8 nM Human immunodeficiency virus 1

Organism

Organism UniProt Comment Textmining
Human immunodeficiency virus 1
-
-
-